Skip to Content

1,203 Results Found

  • Review
  • Open Access
26 Citations
6,431 Views
11 Pages

Epstein–Barr virus (EBV) was discovered in 1964 in the cell line of Burkitt lymphoma and became first known human oncogenic virus. EBV belongs to the Herpesviridae family, and is present worldwide as it infects 95% of people. Infection with EBV...

(This article belongs to the Special Issue Molecular Diagnostic and Epidemiology of Viral Infections)
  • Review
  • Open Access
52 Citations
8,191 Views
22 Pages

The Role of NK Cells in EBV Infection and EBV-Associated NPC

  • Yi Tian Png,
  • Audrey Zhi Yi Yang,
  • Mei Ying Lee,
  • Magdalene Jahn May Chua and
  • Chwee Ming Lim

15 February 2021

A vast majority of the population worldwide are asymptomatic carriers of Epstein-Barr Virus (EBV). However, some infected individuals eventually develop EBV-related cancers, including Nasopharyngeal Carcinoma (NPC). NPC is one of the most common EBV-...

(This article belongs to the Topic The Role of Innate Lymphocytes in Infection and Host Immunity)
  • Review
  • Open Access
50 Citations
7,920 Views
23 Pages

EBV and Lymphomagenesis

  • Daniel G. Sausen,
  • Ayeman Basith and
  • Syed Muqeemuddin

4 April 2023

The clinical significance of Epstein–Barr virus (EBV) cannot be understated. Not only does it infect approximately 90% of the world’s population, but it is also associated with numerous pathologies. Diseases linked to this virus include h...

(This article belongs to the Special Issue Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment)
  • Feature Paper
  • Article
  • Open Access
27 Citations
6,659 Views
19 Pages

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas

  • Octavia Ramayanti,
  • Mitch Brinkkemper,
  • Sandra A. W. M. Verkuijlen,
  • Leni Ritmaleni and ,
  • Mei Lin Go and
  • Jaap M. Middeldorp
  • + 1 author+ 0 author

22 March 2018

Epstein-Barr virus (EBV) persists in nasopharyngeal (NPC) and gastric carcinomas (EBVaGC) in a tightly latent form. Cytolytic virus activation (CLVA) therapy employs gemcitabine and valproic acid (GCb+VPA) to reactivate latent EBV into the lytic phas...

(This article belongs to the Special Issue Epstein–Barr Virus Associated Cancers)
  • Article
  • Open Access
16 Citations
6,498 Views
23 Pages

Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma

  • Su Jin Choi,
  • Eunhyun Ryu,
  • Seulki Lee,
  • Sora Huh and ,
  • Yu Su Shin,
  • Byung Woog Kang,
  • Jong Gwang Kim,
  • Hyosun Cho and
  • Hyojeung Kang
  • + 4 authors+ 0 author

Cordyceps species are known to contain numerous bioactive compounds, including cordycepin. Extracts of Cordyceps militaris (CME) are used in diverse medicinal purposes because of their bioactive components. Cordycepin, one of the active components of...

(This article belongs to the Special Issue Natural Products against Viral Infections)
  • Article
  • Open Access
2 Citations
1,868 Views
18 Pages

The EBV-Positive Tumor Methylome Is Distinct from EBV-Negative in Diffuse Large B-Cell Lymphoma

  • Ashley K. Volaric,
  • Ramiro Barrantes-Reynolds,
  • Karine Sahakyan,
  • Yuri Fedoriw and
  • Seth Frietze

13 September 2025

Backgrounds: Epstein–Barr virus (EBV) is implicated in the pathogenesis of different B-cell lymphomas and lymphoproliferative disorders, including diffuse large B-cell lymphoma (DLBCL) arising in immunodeficiency settings. Despite its clinical...

(This article belongs to the Section Infectious Agents and Cancer)
  • Article
  • Open Access
5 Citations
3,786 Views
13 Pages

Genetic Patterns Found in the Nuclear Localization Signals (NLSs) Associated with EBV-1 and EBV-2 Provide New Insights into Their Contribution to Different Cell-Type Specificities

  • Louise Zanella,
  • María Elena Reyes,
  • Ismael Riquelme,
  • Michel Abanto and ,
  • Daniela León,
  • Tamara Viscarra,
  • Carmen Ili and
  • Priscilla Brebi
  • + 3 authors+ 0 author

24 May 2021

The Epstein–Barr virus (EBV) is a globally dispersed pathogen involved in several human cancers of B-cell and non-B-cell origin. EBV has been classified into EBV-1 and EBV-2, which have differences in their transformative ability. EBV-1 can transform...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Review
  • Open Access
8 Citations
5,940 Views
19 Pages

Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region

  • Patricia Bott,
  • Ilske Oschlies,
  • Andreas Radeloff and
  • Maureen Loewenthal

15 April 2022

EBV-positive mucocutaneous ulcer (EBV-MCU) was classified as a rare new entity of the lymphoproliferative B-cell diseases by the WHO in 2017 and must be distinguished from head and neck squamous cell carcinoma by early biopsy. The aim of the study is...

(This article belongs to the Section Head and Neck Oncology)
  • Review
  • Open Access
201 Citations
22,075 Views
20 Pages

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma

  • Hisashi Iizasa,
  • Asuka Nanbo,
  • Jun Nishikawa,
  • Masahisa Jinushi and
  • Hironori Yoshiyama

29 November 2012

The ubiquitous Epstein-Barr virus (EBV) is associated with several human tumors, which include lymphoid and epithelial malignancies. It is known that EBV persistently infects the memory B cell pool of healthy individuals by activating growth and surv...

(This article belongs to the Special Issue Recent Progress in EBV Research)
  • Article
  • Open Access
19 Citations
7,854 Views
16 Pages

EBV-Associated Cancer and Autoimmunity: Searching for Therapies

  • Giovanni Capone,
  • Candida Fasano,
  • Guglielmo Lucchese,
  • Michele Calabrò and
  • Darja Kanduc

5 February 2015

Epstein-Barr virus (EBV) infects B-, T-, and NK cells and has been associated not only with a wide range of lymphoid malignancies but also with autoimmune diseases such as lupus erythematosus, rheumatoid arthritis and, in particular, multiple scleros...

(This article belongs to the Special Issue Cancer Vaccines)
  • Review
  • Open Access
19 Citations
5,818 Views
12 Pages

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies

  • Angela Kwok-Fung Lo,
  • Christopher W. Dawson,
  • Hong Lok Lung,
  • Ka-Leung Wong and
  • Lawrence S. Young

17 July 2020

Epstein-Barr virus (EBV) is closely linked to the development of a number of human cancers. EBV-associated malignancies are characterized by a restricted pattern of viral latent protein expression which is sufficient for the virus to both initiate an...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Communication
  • Open Access
4 Citations
2,665 Views
9 Pages

Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is characterized by chronic or recurrent infectious mononucleosis-like symptoms and is associated with EBV-associated T/natural killer (NK)-cell lymphoproliferative disorders, which freq...

(This article belongs to the Special Issue Epstein–Barr Virus Infection and Associated Diseases 2.0)
  • Review
  • Open Access
22 Citations
10,626 Views
24 Pages

EBV Association with Lymphomas and Carcinomas in the Oral Compartment

  • B. J. H. Ward,
  • Danielle L. Schaal,
  • Ebubechukwu H. Nkadi and
  • Rona S. Scott

1 December 2022

Epstein–Barr virus (EBV) is an oncogenic human herpesvirus infecting approximately 90% of the world’s population. The oral cavity serves a central role in the life cycle, transmission, and pathogenesis of EBV. Transmitted to a new host vi...

(This article belongs to the Special Issue Epstein-Barr Virus Replication and Pathogenesis)
  • Review
  • Open Access
721 Views
27 Pages

6 September 2026

Epstein–Barr virus (EBV) is an oncogenic human gammaherpesvirus that is prevalent worldwide. Although over 95% of the world’s population harbors this pathogen, the vast majority of infections are asymptomatic, largely due to immune system...

(This article belongs to the Special Issue Immune Evasion and Viral Carcinogenesis)
  • Article
  • Open Access
1 Citations
969 Views
21 Pages

Identification of a New Phosphorylated Host Interactor of the Epstein–Barr Virus (EBV) Kinase BGLF4 Suggests Key Points for EBV-Specific Antiviral Drug Targeting

  • Melanie Kögler,
  • Christina Wangen,
  • Alena Hammerschmitt,
  • Debora Obergfäll and ,
  • Friedrich Hahn and
  • Manfred Marschall
  • + 1 author+ 0 author

Epstein–Barr virus (EBV) is a human pathogenic and oncogenic herpesvirus, with worldwide importance, at times associated with serious to life-threatening symptoms, especially in immunocompromised hosts. The available preventive options against...

(This article belongs to the Section Molecular Microbiology)
  • Article
  • Open Access
11 Citations
4,037 Views
22 Pages

Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection

  • Leonn Mendes Soares Pereira,
  • Eliane dos Santos França,
  • Iran Barros Costa,
  • Igor Tenório Lima and ,
  • Amaury Bentes Cunha Freire,
  • Francisco Lúzio de Paula Ramos,
  • Talita Antonia Furtado Monteiro,
  • Olinda Macedo,
  • Rita Catarina Medeiros Sousa and
  • Antonio Carlos Rosário Vallinoto
  • + 7 authors+ 2 authors

18 January 2022

Background: The aim of the present study was to evaluate the immunological profile of adult HIV-1+ patients coinfected with primary Epstein–Barr virus (EBV) infection who were free of antiretroviral drugs and inhabitants of the Brazilian Amazon...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
815 Views
11 Pages

Analysis of Tonsillar NK Cell Markers in Pediatric Epstein–Barr Virus (EBV) Asymptomatic Infection and EBV-Associated Hodgkin Lymphoma

  • Natalia M. Ferressini Gerpe,
  • María E. Amarillo,
  • Oscar Jimenez,
  • Agustina Moyano and ,
  • María S. Caldirola,
  • María I. Gaillard,
  • Elena De Matteo and
  • Paola Chabay
  • + 3 authors+ 0 author

12 June 2026

In Argentina, a high incidence of EBV-associated lymphomas was demonstrated in young children. Natural killer (NK) cells, particularly, IFN-γ-producing CD56bright NK cells, have been reported to play a key role in asymptomatic EBV infection in...

(This article belongs to the Special Issue EBV Infection and EBV-Associated Lymphomas in Children)
  • Review
  • Open Access
17 Citations
8,084 Views
27 Pages

The Role of Coinfections in the EBV–Host Broken Equilibrium

  • Yessica Sánchez-Ponce and
  • Ezequiel M. Fuentes-Pananá

19 July 2021

The Epstein–Barr virus (EBV) is a well-adapted human virus, and its infection is exclusive to our species, generally beginning in the childhood and then persisting throughout the life of most of the affected adults. Although this infection generally...

(This article belongs to the Section Animal Viruses)
  • Review
  • Open Access
65 Citations
8,945 Views
26 Pages

Oncogenic Properties of the EBV ZEBRA Protein

  • Diego Germini,
  • Fatimata Bintou Sall,
  • Anna Shmakova,
  • Joëlle Wiels and ,
  • Svetlana Dokudovskaya,
  • Emmanuel Drouet and
  • Yegor Vassetzky
  • + 2 authors+ 0 author

5 June 2020

Epstein Barr Virus (EBV) is one of the most common human herpesviruses. After primary infection, it can persist in the host throughout their lifetime in a latent form, from which it can reactivate following specific stimuli. EBV reactivation is trigg...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Review
  • Open Access
75 Citations
14,296 Views
34 Pages

13 November 2017

Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are as yet, no EBV-targeted therapies available. Like other herpesv...

(This article belongs to the Special Issue Viral Infection and Apoptosis)
  • Review
  • Open Access
848 Views
21 Pages

Modulation of DNA Damage by Epstein–Barr Virus (EBV)

  • Emily DiMaulo-Milk and
  • Blossom Damania

18 September 2026

Epstein–Barr Virus (EBV) is an oncogenic gammaherpesvirus present in >95% of the adult population. EBV is responsible for nearly 2% of the global cancer burden and is a contributing factor in the development and progression of both epithelia...

(This article belongs to the Special Issue Epstein–Barr Virus: Mechanisms in Autoimmunity and Oncogenesis)
  • Article
  • Open Access
19 Citations
8,200 Views
13 Pages

1 December 2017

Epstein-Barr virus (EBV) is an oncogenic herpesvirus that is ubiquitous in the human population. Early after EBV infection in vitro, primary human B cells undergo a transient period of hyper-proliferation, which results in replicative stress and DNA...

(This article belongs to the Special Issue Viruses and the DNA Damage Response)
  • Article
  • Open Access
2 Citations
1,631 Views
18 Pages

IRF4 Mediates Immune Evasion to Facilitate EBV Transformation

  • Ling Wang,
  • Culton R. Hensley,
  • Jahan Rifat,
  • Adam D. Walker and ,
  • Katharine Ning,
  • Jonathan P. Moorman,
  • Zhi Q. Yao and
  • Shunbin Ning
  • + 3 authors+ 0 author

24 June 2025

The lymphocyte-specific transcription factor interferon regulatory factor 4 (IRF4) is a key player in immune evasion in cancers, with the complex mechanism(s) being barely understood. In this study, we have focused on the role of IRF4 in regulating T...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
7 Citations
3,477 Views
13 Pages

Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer

  • Ewa Stępień,
  • Małgorzata Strycharz-Dudziak,
  • Maria Malm,
  • Bartłomiej Drop and
  • Małgorzata Polz-Dacewicz

6 August 2021

The Epstein–Barr virus (EBV) is associated with the development of various epithelial malignancies including cancer in the head and neck region. Several studies have shown that Toll-like receptors (TLRs) are required for an innate immune response to...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Review
  • Open Access
17 Citations
5,592 Views
21 Pages

The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies

  • Maria G. Desimio,
  • Daniela A. Covino,
  • Beatrice Rivalta,
  • Caterina Cancrini and
  • Margherita Doria

22 March 2023

The Epstein–Barr virus (EBV) is a ubiquitous herpesvirus most often transmitted during infancy and infecting the vast majority of human beings. Usually, EBV infection is nearly asymptomatic and results in life-long persistency of the virus in a...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
77 Citations
16,837 Views
17 Pages

How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection

  • Guo-Long Bu,
  • Chu Xie,
  • Yin-Feng Kang,
  • Mu-Sheng Zeng and
  • Cong Sun

27 October 2022

The Epstein–Barr virus (EBV) is associated with a variety of human malignancies, including Burkitt’s lymphoma, Hodgkin’s disease, nasopharyngeal carcinoma and gastric cancers. EBV infection is crucial for the oncogenesis of its host...

(This article belongs to the Special Issue Epstein-Barr Virus Replication and Pathogenesis)
  • Review
  • Open Access
54 Citations
10,256 Views
24 Pages

Emerging Themes from EBV and KSHV microRNA Targets

  • Dhivya Ramalingam,
  • Philippe Kieffer-Kwon and
  • Joseph M. Ziegelbauer

21 September 2012

EBV and KSHV are both gamma-herpesviruses which express multiple viral microRNAs. Various methods have been used to investigate the functions of these microRNAs, largely through identification of microRNA target genes. Surprisingly, these related vir...

(This article belongs to the Special Issue Viruses and miRNAs)
  • Review
  • Open Access
9 Citations
3,917 Views
12 Pages

Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer

  • Aviva Atri-Schuller,
  • Hassan Abushukair,
  • Ludimila Cavalcante,
  • Stijn Hentzen and ,
  • Azhar Saeed and
  • Anwaar Saeed
  • + 1 author+ 0 author

18 November 2022

Although most people are infected with Epstein-Barr Virus (EBV) during their lifetime, only a minority of them develop an EBV-associated malignancy. EBV acts in both direct and indirect ways to transform infected cells into tumor cells. There are mul...

(This article belongs to the Special Issue Targeting Tumor Microenvironment for Cancer Therapy)
  • Review
  • Open Access
5 Citations
3,524 Views
16 Pages

26 September 2024

The Herpesviridae include the Epstein–Barr Virus (EBV) and the Kaposi Sarcoma-associated Herpesvirus (KSHV), both of which are oncogenic gamma-herpesviruses. These viruses manipulate host cellular mechanisms, including through ubiquitin-mediate...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
16 Citations
5,251 Views
14 Pages

26 January 2022

Deregulation of the ubiquitin–proteasome system (UPS) plays a critical role in the development of numerous human cancers. Epstein–Barr virus (EBV), the first known human tumor virus, has evolved distinct molecular mechanisms to manipulate...

(This article belongs to the Special Issue The Role of the Ubiquitin-Proteasome-System in Human Cancer)
  • Brief Report
  • Open Access
9 Citations
2,819 Views
5 Pages

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine

  • Henry H. Balfour,
  • Madeline R. Meirhaeghe,
  • Arianna L. Stancari,
  • Jennifer M. Geris and ,
  • Lawrence M. Condon and
  • Laurel E. Cederberg
  • + 1 author+ 0 author

26 August 2022

Background: To better understand the epidemiology of primary Epstein-Barr virus (EBV) infection and to identify EBV-naïve candidates eligible to receive a prophylactic EBV vaccine, we screened freshmen from the University of Minnesota Class of 2...

(This article belongs to the Section Nucleic Acid (DNA and mRNA) Vaccines)
  • Article
  • Open Access
9 Citations
2,862 Views
15 Pages

Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer

  • Anna Polz,
  • Kamal Morshed,
  • Bartłomiej Drop and
  • Małgorzata Polz-Dacewicz

22 February 2024

The high incidence of, and mortality from, head and neck cancers (HNCs), including those related to Epstein–Barr virus (EBV), constitute a major challenge for modern medicine, both in terms of diagnosis and treatment. Therefore, many researcher...

(This article belongs to the Section Molecular Oncology)
  • Feature Paper
  • Article
  • Open Access
1,518 Views
16 Pages

Are Intravenous Immunoglobulins Effective in Preventing Primary EBV Infection in Pediatric Kidney Transplant Recipients?

  • Nicola Bertazza Partigiani,
  • Veronica Bertozzi,
  • Maria Sangermano and
  • Elisa Benetti

2 November 2025

Background and Objectives: Primary Epstein–Barr virus (EBV) infection in pediatric kidney transplant recipients with donor/recipient mismatch (D+/R−) carries the highest risk of post-transplant lymphoproliferative disorder (PTLD). Current...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
5 Citations
3,469 Views
17 Pages

24 October 2024

Epstein–Barr virus (EBV), a member of the gamma herpesvirus, is the first identified human oncovirus and is associated with various malignancies. Understanding the intricate interactions between EBV antigens and cellular pathways is crucial to...

(This article belongs to the Special Issue Herpesviruses and Associated Diseases)
  • Article
  • Open Access
353 Views
18 Pages

TLR2 and TLR9 in Brain Cancer Patients in Relation to EBV Status

  • Michał Brzozowski,
  • Magdalena Góralczyk,
  • Sylwester Bogacki and
  • Małgorzata Polz-Dacewicz

21 September 2026

Toll-like receptors (TLRs) play a significant role in the tumor microenvironment, including in brain tumors, as their activation can both support an anti-tumor response and promote tumor progression through chronic inflammation. However, the precise...

(This article belongs to the Special Issue Glioblastoma: Molecular Pathogenesis and Treatment)
  • Review
  • Open Access
12 Citations
4,506 Views
15 Pages

7 December 2023

The oncogenic and persistent Epstein Barr virus (EBV) is carried by more than 95% of the human adult population. While asymptomatic in most of these, EBV can cause a wide variety of malignancies of lymphoid or epithelial cell origin. Some of these ar...

(This article belongs to the Special Issue Epstein–Barr Virus (EBV) Associated Cancers)
  • Article
  • Open Access
16 Citations
5,230 Views
12 Pages

19 August 2022

(1) Background: CMV and EBV co-infections can affect the HIV disease progression by modulating the immune system. The disease dynamics can differ in HIV-positive adults and children. In Pakistan, HIV is rapidly expanding, especially in children; howe...

(This article belongs to the Special Issue HIV and Co-infections: Updates and Insights)
  • Review
  • Open Access
63 Citations
6,507 Views
16 Pages

28 October 2020

Epstein–Barr-virus-associated Gastric Cancer (EBVaGC) comprises approximately 10% of global gastric cancers and is known to be the most hypermethylated of all tumor types. EBV infection has been shown to directly induce the hypermethylation of...

(This article belongs to the Special Issue Epigenetics and Viral Infection)
  • Review
  • Open Access
83 Citations
9,708 Views
22 Pages

29 October 2021

The Epstein–Barr Virus (EBV) principal oncoprotein Latent Membrane Protein 1 (LMP1) is a member of the Tumor Necrosis Factor Receptor (TNFR) superfamily with constitutive activity. LMP1 shares many features with Pathogen Recognition Receptors (PRRs),...

(This article belongs to the Special Issue Epstein-Barr Virus Infection in Cancer)
  • Article
  • Open Access
6 Citations
3,429 Views
24 Pages

EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma

  • Nuray Akyüz,
  • Snjezana Janjetovic,
  • Susanne Ghandili,
  • Carsten Bokemeyer and
  • Judith Dierlamm

25 August 2023

Abnormalities of the long arm of chromosome 1 (1q) represent the most frequent secondary chromosomal aberrations in Burkitt lymphoma (BL) and are observed almost exclusively in EBV-negative BL cell lines (BL-CLs). To verify chromosomal abnormalities,...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
20 Citations
5,111 Views
17 Pages

EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)

  • Magda Zanelli,
  • Francesca Sanguedolce,
  • Andrea Palicelli,
  • Maurizio Zizzo and ,
  • Giovanni Martino,
  • Cecilia Caprera,
  • Valentina Fragliasso,
  • Alessandra Soriano,
  • Luca Valle and
  • Stefano Ascani
  • + 9 authors+ 4 authors

12 September 2021

EBV is the most common persistent virus in humans. The interaction of EBV with B lymphocytes, which are considered the virus reservoir, is at the base of the life-long latent infection. Under circumstances of immunosuppression, the balance between vi...

(This article belongs to the Special Issue Gastrointestinal Malignancies in the Era of Precision Oncology: From Bench to Bedside and Back Again)
  • Review
  • Open Access
20 Citations
22,178 Views
34 Pages

Activated cytotoxic CD4 T cells (HLA-DR+) play an important role in the control of EBV infection, especially in cells with latency I (EBNA-1). One of the evasion mechanisms of these latency cells is generated by gp42, which, via peripherally binding...

(This article belongs to the Section Viral Pathogens)
  • Review
  • Open Access
15 Citations
9,386 Views
23 Pages

Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma

  • Mohamed Nazem Alibrahim,
  • Annunziata Gloghini and
  • Antonino Carbone

25 April 2025

Classic Hodgkin lymphoma (cHL) in patients with immune deficiency/dysregulation represents a critical unmet need in hematology, demanding the appropriate revision of classification and therapeutic paradigms. Epstein–Barr virus (EBV) is a pivota...

(This article belongs to the Special Issue Oncogenesis of Lymphoma)
  • Systematic Review
  • Open Access
1 Citations
1,586 Views
21 Pages

Experimental Therapies in Multiple Sclerosis: Epstein–Barr Virus and Potential EBV-Related Therapeutic Strategies—A Systematic Review

  • Julia Bartczak,
  • Piotr Gronowski,
  • Martyna Małek,
  • Aleksandra Denkiewicz and ,
  • Olga Grodzka,
  • Piotr Chądzyński and
  • Izabela Domitrz
  • + 2 authors+ 0 author

26 May 2026

Background/Objectives: Multiple sclerosis (MS) constitutes a chronic autoimmune, inflammatory, and neurodegenerative disease, with dissemination in space and time, warranting diagnosis. Epstein–Barr virus (EBV) is increasingly recognized as a k...

(This article belongs to the Special Issue Multiple Sclerosis and Demyelinating Disease: Clinical Treatment and Management)
  • Article
  • Open Access
5 Citations
3,845 Views
17 Pages

Drugs That Mimic Hypoxia Selectively Target EBV-Positive Gastric Cancer Cells

  • Blue-leaf A. Cordes,
  • Andrea Bilger,
  • Richard J. Kraus,
  • Ella T. Ward-Shaw and ,
  • Madeline R. Labott,
  • Shinhyo Lee,
  • Paul F. Lambert and
  • Janet E. Mertz
  • + 3 authors+ 0 author

19 March 2023

Latent infection of Epstein-Barr virus (EBV) is associated with lymphoid and epithelial cell cancers, including 10% of gastric carcinomas. We previously reported that hypoxia inducible factor-1α (HIF-1α) induces EBV’s latent-to-lyti...

(This article belongs to the Special Issue Viruses in Cancer Etiology)
  • Case Report
  • Open Access
4,167 Views
9 Pages

EBV-Positive Nodal T- and NK-Cell Lymphoma Mimicking Anaplastic Large Cell Lymphoma: A Case Report

  • Brooj Abro,
  • Pamela Allen,
  • Saja Asakrah,
  • Kyle Bradley and
  • Linsheng Zhang

EBV-positive nodal T- and NK-cell lymphoma (EBV+ NT/NKCL) is a recently recognized entity in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Notably, CD30 positivity is frequently observed in (EBV+ NT/NKCL),...

  • Review
  • Open Access
34 Citations
5,782 Views
11 Pages

miRNAs: EBV Mechanism for Escaping Host’s Immune Response and Supporting Tumorigenesis

  • Snježana Židovec Lepej,
  • Maja Matulić,
  • Paula Gršković,
  • Mirjana Pavlica and ,
  • Leona Radmanić and
  • Petra Korać
  • + 1 author+ 0 author

Epstein-Barr virus (EBV) or human herpesvirus 4 (HHV-4) is a ubiquitous human oncogenic virus, and the first human virus found to express microRNAs (miRNAs). Its genome contains two regions encoding more than 40 miRNAs that regulate expression of bot...

(This article belongs to the Section Human Pathogens)
  • Review
  • Open Access
44 Citations
19,389 Views
22 Pages

Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments

  • Oren Shechter,
  • Daniel G. Sausen,
  • Elisa S. Gallo,
  • Harel Dahari and
  • Ronen Borenstein

19 November 2022

Epstein–Barr virus (EBV) is one of eight known herpesviruses with the potential to infect humans. Globally, it is estimated that between 90–95% of the population has been infected with EBV. EBV is an oncogenic virus that has been strongly...

(This article belongs to the Special Issue Herpesviruses and Their Host Cells: EBV- and KSHV-Associated Diseases)
  • Article
  • Open Access
2 Citations
3,080 Views
11 Pages

APOBR Is Downregulated in EBV+ Tonsils of Children with Obstructive Sleep-Disordered Breathing

  • Regie Lyn P. Santos-Cortez,
  • Helen Z. Gomez,
  • Christina L. Elling,
  • Landen Mayher and ,
  • Obinna R. Diala,
  • Colin Gardner,
  • Kiera Willford,
  • Valerie C. Zamora,
  • Ashley Agyepong and
  • Brian W. Herrmann
  • + 15 authors+ 10 authors

14 October 2024

Background: Obstructive sleep-disordered breathing (oSDB) is a heterogeneous phenotype that is increasing in prevalence worldwide and has many potential comorbidities that could severely affect quality of life. There is a need to identify biomarkers...

(This article belongs to the Special Issue Feature Papers in Human Genomics and Genetic Diseases 2024)
  • Review
  • Open Access
74 Citations
7,567 Views
13 Pages

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy

  • Maria Grazia Rodriquenz,
  • Giandomenico Roviello,
  • Alberto D’Angelo,
  • Daniele Lavacchi and ,
  • Franco Roviello and
  • Karol Polom
  • + 1 author+ 0 author

Gastric cancers have been historically classified based on histomorphologic features. The Cancer Genome Atlas network reported the comprehensive identification of genetic alterations associated with gastric cancer, identifying four distinct subtypes&...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)

of 25